Skip to content
The People's CodeSearch
Menu

Changes to the Code

H.R. 10937 · Preserving Rules Ordered for The Entities Covered Through 340B Act of 2026 ·

PROTECT 340B Act of 2026

In committee · step 2 of 5

Sections are cited like “7 U.S.C. § 2012”: 7 of the , 2012.

42 U.S.C. § 256b Limitation on prices of drugs purchased by covered entities

+2 −0Shown
More for 42 U.S.C. § 256b
Read § 256bOnly this section
1 change the bill asks for here, 1 carried out
  1. Carried out:

    Section 340B(a)(5) of the Public Health Service Act (42 U.S.C. 256b(a)(5)) is amended by adding at the end the following new subparagraph:(E) Provision of information to contracted entity for Medicaid claims review.— A covered entity shall furnish to the entity with a contract in effect under section 1927(l) of the Social Security Act, upon request of such entity, the data described in paragraph (2)(A)(i) of such section..

§ 256b(a)Requirements for agreement with Secretary(5)–(7)

Start of § 256b to (a)(5)(B) unchanged ·

(C) Auditing A covered entity shall permit the Secretary and the manufacturer of a covered outpatient drug that is subject to an agreement under this subsection with the entity (acting in accordance with procedures established by the Secretary relating to the number, duration, and scope of audits) to audit at the Secretary’s or the manufacturer’s expense the records of the entity that directly pertain to the entity’s compliance with the requirements described in subparagraphs2 (A) or (B) with respect to drugs of the manufacturer.

(D) Additional sanction for noncompliance If the Secretary finds, after audit as described in subparagraph (C) and after notice and hearing, that a covered entity is in violation of a requirement described in subparagraphs 2 (A) or (B), the covered entity shall be liable to the manufacturer of the covered outpatient drug that is the subject of the violation in an amount equal to the reduction in the price of the drug (as described in subparagraph (A)) provided under the agreement between the entity and the manufacturer under this paragraph.

(E) [inserted: Provision of information to contracted entity for Medicaid claims review.—] [inserted: A covered entity shall furnish to the entity with a contract in effect under section 1927(l) of the Social Security Act, upon request of such entity, the data described in paragraph (2)(A)(i) of such section.]

(6) Treatment of distinct units of hospitals In the case of a covered entity that is a distinct part of a hospital, the hospital shall not be considered a covered entity under this paragraph unless the hospital is otherwise a covered entity under this subsection.

(7) Certification of certain covered entities

Rest of § 256b unchanged ·

Public Health Service Act § 2730 Requirements relating to the 340B drug discount program New section

+45 −0Shown
More for Public Health Service Act § 2730
1 change the bill asks for here, 1 carried out
  1. Carried out:

    Subpart II of part A of title XXVII of the Public Health Service Act (42 U.S.C. 300gg–11 et seq.) is amended by adding at the end the following new section:2730. Requirements relating to the 340B drug discount program (a) In general.— A group health plan, a health insurance issuer offering group or individual health insurance coverage, or a pharmacy benefit manager may not discriminate against a covered entity (as defined in subsection (d)(1)), a specified pharmacy (as defined in subsection (d)(2)), or a participant, beneficiary, or enrollee of such plan or coverage by imposing requirements, exclusions, reimbursement terms, or other conditions on such entity or pharmacy that differ from those applied to entities or pharmacies that are not covered entities or specified pharmacies on the basis that the entity or pharmacy is a covered entity or specified pharmacy or that the entity or pharmacy dispenses 340B drugs, including by taking any action prohibited under subsection (b). (b) Specified prohibited actions.— A group health plan, a health insurance issuer offering group or individual health insurance coverage, or a pharmacy benefit manager may not discriminate against a covered entity, a specified pharmacy, or a participant, beneficiary, or enrollee of such plan or coverage by doing any of the following: (1) Reimbursing a covered entity or specified pharmacy for a quantity of a 340B drug (as defined in subsection (d)) in an amount less than such plan, issuer, or manager (as applicable) would pay to any other similarly situated (as specified by the Secretary) entity or pharmacy that is not a covered entity or a specified pharmacy for such quantity of such drug on the basis that the entity or pharmacy is a covered entity or specified pharmacy or that the entity or pharmacy dispenses 340B drugs. (2) Imposing any terms or conditions on covered entities or specified pharmacies with respect to any of the following that differ from such terms or conditions applied to other similarly situated entities or pharmacies that are not covered entities or specified pharmacies on the basis that the entity or pharmacy is a covered entity or specified pharmacy or that the entity or pharmacy dispenses 340B drugs: (A) Fees, chargebacks, clawbacks, adjustments, or other assessments. (B) Professional dispensing fees. (C) Restrictions or requirements regarding participation in standard or preferred pharmacy networks. (D) Requirements relating to the frequency or scope of audits or to inventory management systems using generally accepted accounting principles. (E) Any other restrictions, conditions, practices, or policies that, as specified by the Administrator of the Health Resources and Services Administration, interfere with the ability of a covered entity to maximize the value of discounts provided under section 340B. (3) Interfering with an individual’s choice to receive a 340B drug from a covered entity or specified pharmacy, whether in person or via direct delivery, mail, or other form of shipment. (4) Requiring a covered entity or specified pharmacy to identify, either directly or through a third party, 340B drugs. (5) Refusing to contract with a covered entity or specified pharmacy for reasons other than those that apply equally to entities or pharmacies that are not covered entities or specified pharmacies, or on the basis that— (A) the entity or pharmacy is a covered entity or a specified pharmacy; or (B) the entity or pharmacy is described in any of subparagraphs (A) through (O) of section 340B(a)(4). (6) With respect to a group health plan or health insurance issuer for health insurance coverage, denying coverage of a drug on the basis that such drug is a 340B drug. (c) Enforcement mechanism for pharmacy benefit managers.— The Secretary shall impose a civil monetary penalty on any pharmacy benefit manager that violates the requirements of this section. Such penalty shall not exceed $5,000 per violation per day. The Secretary shall issue proposed regulations to implement this subsection not later than 60 days after the date of the enactment of this subsection and shall finalize such regulations not later than 180 days after such date of enactment. (d) Definitions.— For purposes of this section: (1) Covered entity.— The term covered entity has the meaning given such term in section 340B(a)(4). (2) Specified pharmacy.— The term specified pharmacy means a pharmacy with which a covered entity has contracted to dispense 340B drugs on behalf of the covered entity whether distributed in person or via mail. (3) 340B drug.— The term 340B drug means a drug that is— (A) a covered outpatient drug (as defined for purposes of section 340B); and (B) purchased under an agreement in effect under such section..

§ 2730(a)–(d)

§ 2730. [inserted: Requirements relating to the 340B drug discount program]

(a) [inserted: In general.—] [inserted: A group health plan, a health insurance issuer offering group or individual health insurance coverage, or a pharmacy benefit manager may not discriminate against a covered entity (as defined in subsection (d)(1)), a specified pharmacy (as defined in subsection (d)(2)), or a participant, beneficiary, or enrollee of such plan or coverage by imposing requirements, exclusions, reimbursement terms, or other conditions on such entity or pharmacy that differ from those applied to entities or pharmacies that are not covered entities or specified pharmacies on the basis that the entity or pharmacy is a covered entity or specified pharmacy or that the entity or pharmacy dispenses 340B drugs, including by taking any action prohibited under subsection (b).]

(b) [inserted: Specified prohibited actions.—] [inserted: A group health plan, a health insurance issuer offering group or individual health insurance coverage, or a pharmacy benefit manager may not discriminate against a covered entity, a specified pharmacy, or a participant, beneficiary, or enrollee of such plan or coverage by doing any of the following:]

(1) [inserted: Reimbursing a covered entity or specified pharmacy for a quantity of a 340B drug (as defined in subsection (d)) in an amount less than such plan, issuer, or manager (as applicable) would pay to any other similarly situated (as specified by the Secretary) entity or pharmacy that is not a covered entity or a specified pharmacy for such quantity of such drug on the basis that the entity or pharmacy is a covered entity or specified pharmacy or that the entity or pharmacy dispenses 340B drugs.]

(2) [inserted: Imposing any terms or conditions on covered entities or specified pharmacies with respect to any of the following that differ from such terms or conditions applied to other similarly situated entities or pharmacies that are not covered entities or specified pharmacies on the basis that the entity or pharmacy is a covered entity or specified pharmacy or that the entity or pharmacy dispenses 340B drugs:]

(A) [inserted: Fees, chargebacks, clawbacks, adjustments, or other assessments.]

(B) [inserted: Professional dispensing fees.]

(C) [inserted: Restrictions or requirements regarding participation in standard or preferred pharmacy networks.]

(D) [inserted: Requirements relating to the frequency or scope of audits or to inventory management systems using generally accepted accounting principles.]

(E) [inserted: Any other restrictions, conditions, practices, or policies that, as specified by the Administrator of the Health Resources and Services Administration, interfere with the ability of a covered entity to maximize the value of discounts provided under section 340B.]

(3) [inserted: Interfering with an individual’s choice to receive a 340B drug from a covered entity or specified pharmacy, whether in person or via direct delivery, mail, or other form of shipment.]

(4) [inserted: Requiring a covered entity or specified pharmacy to identify, either directly or through a third party, 340B drugs.]

(5) [inserted: Refusing to contract with a covered entity or specified pharmacy for reasons other than those that apply equally to entities or pharmacies that are not covered entities or specified pharmacies, or on the basis that—]

(A) [inserted: the entity or pharmacy is a covered entity or a specified pharmacy; or]

(B) [inserted: the entity or pharmacy is described in any of subparagraphs (A) through (O) of section 340B(a)(4).]

(6) [inserted: With respect to a group health plan or health insurance issuer for health insurance coverage, denying coverage of a drug on the basis that such drug is a 340B drug.]

(c) [inserted: Enforcement mechanism for pharmacy benefit managers.—] [inserted: The Secretary shall impose a civil monetary penalty on any pharmacy benefit manager that violates the requirements of this section. Such penalty shall not exceed $5,000 per violation per day. The Secretary shall issue proposed regulations to implement this subsection not later than 60 days after the date of the enactment of this subsection and shall finalize such regulations not later than 180 days after such date of enactment.]

(d) [inserted: Definitions.—] [inserted: For purposes of this section:]

(1) [inserted: Covered entity.—] [inserted: The term “covered entity” has the meaning given such term in section 340B(a)(4).]

(2) [inserted: Specified pharmacy.—] [inserted: The term “specified pharmacy” means a pharmacy with which a covered entity has contracted to dispense 340B drugs on behalf of the covered entity whether distributed in person or via mail.]

(3) [inserted: 340B drug.—] [inserted: The term “340B drug” means a drug that is—]

(A) [inserted: a covered outpatient drug (as defined for purposes of section 340B); and]

(B) [inserted: purchased under an agreement in effect under such section.]

42 U.S.C. § 1395w–27 Contracts with Medicare+Choice organizations

+2 −0Shown
More for 42 U.S.C. § 1395w–27
Read § 1395w–27Only this section
1 change the bill asks for here, 1 carried out
  1. Carried out:

    Section 1857(f)(3) of the Social Security Act (42 U.S.C. 1395w–27(f)(3)) is amended by adding at the end the following new subparagraph:(H) 340B drug discount program.— Section 1860D–12(b)(8)..

§ 1395w–27(f)–(g)

Start of § 1395w–27 to (f)(3)(E) unchanged ·

(F) Accountability of pharmacy benefit managers for violations of reasonable and relevant contract terms For plan years beginning on or after January 1, 2029, section 1395w–112(b)(9) of this title.

(G) Requirements relating to pharmacy benefit managers For plan years beginning on or after January 1, 2028, section 1395w–112(h) of this title.

(H) [inserted: 340B drug discount program.—] [inserted: Section 1860D–12(b)(8).]

(g) Intermediate sanctions

(1) In general If the Secretary determines that a Medicare+Choice organization with a contract under this section—

Rest of § 1395w–27 unchanged ·

42 U.S.C. § 1395w–112 Requirements for and contracts with prescription drug plan (PDP) sponsors

+2 −0Shown
More for 42 U.S.C. § 1395w–112
Read § 1395w–112Only this section
1 change the bill asks for here, 1 carried out
  1. Carried out:

    Section 1860D–12(b) of the Social Security Act (42 U.S.C. 1395w–112(b)) is amended by adding at the end the following new paragraph:(10) Application of requirements relating to the 340B drug discount program.— Each contract entered into under this subsection with a PDP sponsor shall provide that the requirements of section 2730 of the Public Health Service Act apply to such sponsor, and to any pharmacy …

§ 1395w–112(b)–(c)

Start of § 1395w–112 to (b)(7)(B) unchanged ·

(8) Provision of information related to maximum fair prices Each contract entered into with a PDP sponsor under this part with respect to a prescription drug plan offered by such sponsor shall require the sponsor to provide information to the Secretary as requested by the Secretary for purposes of carrying out section 1320f–3 of this title.

(9) Accountability of pharmacy benefit managers for violations of reasonable and relevant contract terms and conditions For plan years beginning on or after January 1, 2029, each contract entered into with a PDP sponsor under this part with respect to a prescription drug plan offered by such sponsor shall provide that any pharmacy benefit manager acting on behalf of such sponsor has a written agreement with the PDP sponsor under which the pharmacy benefit manager agrees to reimburse the PDP sponsor for any amounts paid by such sponsor under section 1395w–104(b)(1)(F)(iii)(I) of this title to the Secretary as a result of a violation described in such section if such violation is related to a responsibility delegated to the pharmacy benefit manager by such PDP sponsor.

(10) [inserted: Application of requirements relating to the 340B drug discount program.—] [inserted: Each contract entered into under this subsection with a PDP sponsor shall provide that the requirements of section 2730 of the Public Health Service Act apply to such sponsor, and to any pharmacy benefit manager that contracts with such sponsor, in the same manner as such requirements apply with respect to a group health plan, a health insurance issuer, or a pharmacy benefit manager described in such section.]

(c) Waiver of certain requirements to expand choice

(1) Authorizing waiver

(A) In general In the case of an entity that seeks to offer a prescription drug plan in a State, the Secretary shall waive the requirement of subsection (a)(1) that the entity be licensed in that State if the Secretary determines, based on the application and other evidence presented to the Secretary, that any of the grounds for approval of the application described in paragraph (2) have been met.

Rest of § 1395w–112 unchanged ·

42 U.S.C. § 1396a State plans for medical assistance

+4 −2Shown
More for 42 U.S.C. § 1396a
Read § 1396aOnly this section
3 changes the bill asks for here, 3 carried out
  1. Carried out:

    in paragraph (89), by striking and at the end;

  2. Carried out:

    in paragraph (90)(C), by striking the period and inserting ; and; and

  3. Carried out:

    by inserting after paragraph (87) the following new paragraph:(91) provide for a mechanism to furnish to the entity with a contract in effect under section 1927(l), upon request of such entity, the data described in paragraph (2)(A)(ii) of such section and remove from any rebate request described in paragraph (1)(B) of such section any …

§ 1396a(a)Contents(87)–(88)

Start of § 1396a to (a)(87)(B) unchanged ·

(C) each such provider has in place a process to address any violation of a State drug law; and

(D) each such provider has in place a process to disclose to the State Medicaid program the driving history, including any traffic violations, of each such individual driver employed by such provider, including any traffic violations;

(91) [inserted: provide for a mechanism to furnish to the entity with a contract in effect under section 1927(l), upon request of such entity, the data described in paragraph (2)(A)(ii) of such section and remove from any rebate request described in paragraph (1)(B) of such section any claim that is the subject of a notice submitted by such entity under paragraph (2)(C) of such section.]

(88) provide—

(A) beginning not later than January 1, 2027, in the case of 1 of the 50 States and the District of Columbia, for a process to regularly obtain address information for individuals enrolled under such plan (or a waiver of such plan) in accordance with subsection (vv); and

§ 1396a(a)Contents(88)–(90)

(a)(88)(B) unchanged ·

(iii) in the case that such system indicates that an individual enrolled or seeking to enroll under such plan (or waiver of such plan) is enrolled under a State plan (or waiver of such a plan) of another State, for the taking of appropriate action (as determined by the Secretary) to identify whether such an individual resides in the State and disenroll an individual from the State plan of such State if such individual does not reside in such State (unless such individual meets such an exception as the Secretary may specify);

(89) provide that the State shall comply with the eligibility verification requirements under subsection (ww), except that this paragraph shall apply only in the case of the 50 States and the District of Columbia;[struck: and]

(90) beginning January 1, 2030, provide, with respect to an active duty relocated individual (as defined in subsection (yy)(1))—

(A) that, for purposes of determining eligibility for medical assistance under the State plan (or waiver of such plan), such active duty relocated individual is treated as a resident of the State unless such individual voluntarily elects not to be so treated for such purposes;

§ 1396a(a)Contents(90)

(a)(90)(B) unchanged ·

(ii) such individual elects to be removed from such list; and

(C) payment for medical assistance furnished under the State plan (or a waiver of the plan) on behalf of such active duty relocated individual in the military service relocation State (as referred to in subsection (yy)(1)(B)(i)), to the extent that such assistance is available in such military service relocation State in accordance with such guidance as the Secretary may issue to ensure access to such assistance[struck: .][inserted: ; and]

Notwithstanding paragraph (5), if on January 1, 1965, and on the date on which a State submits its plan for approval under this subchapter, the State agency which administered or supervised the administration of the plan of such State approved under subchapter X (or subchapter XVI, insofar as it relates to the blind) was different from the State agency which administered or supervised the administration of the State plan approved under subchapter I (or subchapter XVI, insofar as it relates to the aged), the State agency which administered or supervised the administration of such plan approved under subchapter X (or subchapter XVI, insofar as it relates to the blind) may be designated to administer or supervise the administration of the portion of the State plan for medical assistance which relates to blind individuals and a different State agency may be established or designated to administer or supervise the administration of the rest of the State plan for medical assistance; and in such case the part of the plan which each such agency administers, or the administration of which each such agency supervises, shall be regarded as a separate plan for purposes of this subchapter (except for purposes of paragraph (10)). The provisions of paragraphs (9)(A), (31), and (33) and of section 1396b(i)(4) of this title shall not apply to a religious nonmedical health care institution (as defined in section 1395x(ss)(1) of this title).

For purposes of paragraph (10) any individual who, for the month of August 1972, was eligible for or receiving aid or assistance under a State plan approved under subchapter I, X, XIV, or XVI, or part A of subchapter IV and who for such month was entitled to monthly insurance benefits under subchapter II shall for purposes of this subchapter only be deemed to be eligible for financial aid or assistance for any month thereafter if such individual would have been eligible for financial aid or assistance for such month had the increase in monthly insurance benefits under subchapter II resulting from enactment of Public Law 92–336 not been applicable to such individual.

The requirement of clause (A) of paragraph (37) with respect to a State plan may be waived by the Secretary if he finds that the State has exercised good faith in trying to meet such requirement. For purposes of this subchapter, any child who meets the requirements of paragraph (1) or (2) of section 673(b) of this title shall be deemed to be a dependent child as defined in section 606 of this title and shall be deemed to be a recipient of aid to families with dependent children under part A of subchapter IV in the State where such child resides. Notwithstanding paragraph (10)(B) or any other provision of this subsection, a State plan shall provide medical assistance with respect to an alien who is not lawfully admitted for permanent residence or otherwise permanently residing in the United States under color of law only in accordance with section 1396b(v) of this title.

Rest of § 1396a unchanged ·

42 U.S.C. § 1396r–8 Payment for covered outpatient drugs

+22 −0Shown
More for 42 U.S.C. § 1396r–8
Read § 1396r–8Only this section
1 change the bill asks for here, 1 carried out
  1. Carried out:

    Section 1927 of the Social Security Act (42 U.S.C. 1396r–8) is amended by adding at the end the following new subsection:(l) Review To prevent duplicate discounts.— (1) In general.— Not later than 1 year after the date of the enactment of this subsection, the Secretary shall enter into a contract with a third-party entity (who shall be free of conflicts of interest, as specified by the Secretary) …

§ 1396r–8(k)–(l)

Start of § 1396r–8 to (k)(9) unchanged ·

(10) Retail community pharmacy The term “retail community pharmacy” means an independent pharmacy, a chain pharmacy, a supermarket pharmacy, or a mass merchandiser pharmacy that is licensed as a pharmacy by the State and that dispenses medications to the general public at retail prices. Such term does not include a pharmacy that dispenses prescription medications to patients primarily through the mail, nursing home pharmacies, long-term care facility pharmacies, hospital pharmacies, clinics, charitable or not-for-profit pharmacies, government pharmacies, or pharmacy benefit managers.

(11) Wholesaler The term “wholesaler” means a drug wholesaler that is engaged in wholesale distribution of prescription drugs to retail community pharmacies, including (but not limited to) repackers, distributors, own-label distributors, private-label distributors, jobbers, brokers, warehouses (including distributor’s warehouses, chain drug warehouses, and wholesale drug warehouses) independent wholesale drug traders, and retail community pharmacies that conduct wholesale distributions.

(l) [inserted: Review To prevent duplicate discounts.—]

(1) [inserted: In general.—] [inserted: Not later than 1 year after the date of the enactment of this subsection, the Secretary shall enter into a contract with a third-party entity (who shall be free of conflicts of interest, as specified by the Secretary) for purposes of—]

(A) [inserted: identifying claims for 340B drugs (as defined in section 2730(d) of the Public Health Service Act) for which reimbursement was made under a State plan (or waiver of such plan); and]

(B) [inserted: ensuring such claims are not included in any State rebate request under this section in violation of section 340B(a)(5)(A) of the Public Health Service Act or section 1903(m)(2)(A)(xiii) or 1927(j)(1).]

(2) [inserted: Duties of contracting entity.—]

(A) [inserted: In general.—] [inserted: The entity with a contract in effect under paragraph (1) shall—]

(i) [inserted: request and review, in the most efficient and least burdensome manner practicable—]

(I) [inserted: claims level data from covered entities (as defined in section 340B of the Public Health Service Act) itemizing 340B drugs dispensed to individuals enrolled under a State plan (or waiver of such plan); and]

(II) [inserted: claims level rebate file data from State agencies administering such plan (or such waiver);]

(ii) [inserted: request, receive, and maintain data described in either of subclauses (I) and (II) of clause (i) in a confidential manner; and]

(iii) [inserted: notify the State and the Secretary of any violation described in paragraph (1)(B) to ensure that such violation is remedied.]

(B) [inserted: Retrospective submission of data.—] [inserted: In requesting and reviewing claims level data described in subparagraph (A)(i)(I) from a covered entity, the entity with a contract in effect under paragraph (1) shall allow such covered entity the option of submitting such data on a retrospective basis through a data file or another method that does not exclusively require point-of-sale identification.]

Step through the changes